Eris Lifesciences achieves a 12.6% year-on-year revenue increase in Q2 FY27, driven by growth in diabetes products, including ...
A US judge rules in favor of Eli Lilly, allowing its weight-loss drug advertisements to continue, despite Novo Nordisk's ...
The experimental drug ris-rez, developed by GSK and Hansoh Pharmaceutical, significantly delays disease progression in ...
China's drug regulator has approved Bayer's blood thinner Asundexian, promising a breakthrough in stroke prevention amid ...
AstraZeneca's late-stage trial data reveals significant improvements in overall survival for advanced stomach cancer patients using the drug sone-ve, outperforming chemotherapy and raising potential ...
Biocon has secured a license to introduce its Stelara biosimilar in nine additional countries, expanding treatment access for ...
Roche's investigational cancer drug divarasib significantly lowers the risk of death for patients with KRAS G12C-mutated ...
Takeda Pharmaceutical aims for regulatory approval in Japan for its promising gastric cancer drug, TAK-921, following ...
A groundbreaking study reveals that Amgen's Imdelltra, when combined with AstraZeneca's immunotherapy Imfinzi, significantly ...
The inclusion of Dr. Naresh Trehan in a pharmaceutical marketing review panel faces backlash from patient groups over ...
Dr Reddy's Laboratories has introduced two new generic versions of Ozempic, named Obeda Pro and Obeda Plus, to address supply ...
AbbVie announced promising results for its experimental drug lutikizumab in reducing skin lesions from hidradenitis ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results